LatAm-FINGERS lifestyle intervention shows promise for brain health in at‑risk older adults across Latin America, echoing US POINTER trial results
Executive summary: At the 2026 Alzheimer’s Association International Conference, researchers released results from the LatAm‑FINGERS study showing that a structured lifestyle program improved brain health in older adults at risk of dementia throughout Latin America, reinforcing outcomes from the US POINTER trial. The study demonstrates that culturally tailored dementia risk‑reduction interventions can be effective in varied populations, informing public‑health planning and potential investment in preventive brain‑health programs.
Who is involved: The study was led by the Latin American FINGERS network with backing from the Alzheimer’s Association, academic institutions in Brazil, Mexico, Colombia and Chile, and enrolled adults aged 60+ with mild cognitive risk.
Likely next: Full trial data are slated for peer‑reviewed publication later in 2026; researchers will engage regional health ministries on scaling the program, while the Alzheimer’s Association will evaluate incorporating the protocol into its global preventive‑care guidelines.
The LatAm‑FINGERS trial, presented at the 2026 Alzheimer’s Association International Conference, reports that a structured lifestyle program improved cognitive health markers in older adults at risk of dementia in Brazil, Mexico, Colombia and Chile. These findings confirm and extend the results of the US POINTER study, suggesting that multidomain prevention strategies can be adapted across diverse cultural and health‑system contexts. The data add to growing evidence that non‑pharmacologic approaches may play a meaningful role in reducing dementia incidence worldwide.
Timeline
- — EXTRAIT DE LA CONFÉRENCE INTERNATIONALE DE L'ASSOCIATION ALZHEIMER 2026 : UN PROGRAMME AXÉ SUR LE MODE DE VIE AMÉLIORE LA SANTÉ CÉRÉBRALE CHEZ LES PERSONNES ÂGÉES À RISQUE DE DÉMENCE EN AMÉRIQUE LATINE (PR Newswire)
Analysis — what this means
Likely next events
- Full LatAm‑FINGERS results to be presented at AAIC 2026 on July 14, 2026
Sectors affected
- preventive neurology services
- digital health lifestyle platforms
- pharmaceutical Alzheimer’s therapeutics
Historical parallels
- FINGER trial (Finland, 2015) showed a multidomain lifestyle intervention reduced cognitive decline by ~30%
- US POINTER trial (2020‑ongoing) tests a similar multidomain approach in older Americans
Key entities
Sources
Open the full interactive case file on Beyond →
INTELLIGENCE
Social Pulse
AI estimate · not scraped